Treatment of hidradenitis suppurativa with adalimumab in the PIONEER I and II randomized controlled trials reduced indices of systemic inflammation, recognized risk factors for cardiovascular disease

Saved in:
Bibliographic Details
Published in:Clinical and experimental dermatology 2024-11
Main Authors: Kearney, Niamh, Chen, Xin, Bi, Yingtao, Hew, Kinjal, Smith, Kathleen M, Kirby, Brian
Format: Article
Language:English
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0307-6938
1365-2230
DOI:10.1093/ced/llae324